Department Of Digestive & Liver Diseases
Investigator
Elizabeth Verna, MD
Email
ev77@cumc.columbia.edu

Dr. Elizabeth C. Verna manages patients with a variety of liver diseases. Her clinical interests focus on viral hepatitis and liver transplantation as well as the new emerging therapies for hepatitis C, liver cancer, alcoholic and non-alcoholic fatty liver disease and metabolic liver diseases. She also has expertise in the management of end stage liver disease and its complications.

Clinical Studies Managed By This Investigator:
Condition Study Title
Liver Transplant [ CLOSED ] Study for liver transplant recipients using drug (IgG) to prevent Hepatitis C virus (HCV) recurrence
Hepatitis [ CLOSED ] Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) using trial drugs
Liver Transplant [ CLOSED ] A study for liver transplant patients with Chronic HCV using study drug Harvoni
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection using study drugs Sofosbuvir, Velpatasvir and GS-9857
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection using study drug combination Sofosbuvir/Velpatasvir/GS-9857
Hepatitis [ CLOSED ] A study for patients with Chronic Genotype 3 HCV Infection and Cirrhosis using study drugs Sofosbuvir, Velpatasvir and GS-9857
Liver Disease [ CLOSED ] A study for patients with Non-Alcoholic Steatohepatitis (NASH using study drug armachol
Hepatitis [ CLOSED ] A study for patients with Chronic HCV Infection who have not received an NS5A Inhibitor using study drugs Sofosbuvir/Velpatasvir/GS-9857
Hepatitis [ CLOSED ] A study for patients with chronic hepatitis C and advanced heart failure or lung disease using study drug Harvoni
NASH [ CLOSED ] Study of Emricasan in subjects with Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Liver Disease [ CLOSED ] GLIMMER: Study of Drug in Treatment of Pruritus (Itching) in Patients with Primary Biliary Cholangitis
Liver Cancer A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer)
NASH [ CLOSED ] TARGET-NASH: Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis
Hepatitis [ CLOSED ] THE PRIORITIZE STUDY: Study of Oral Regimens for Hepatitis C
Hepatitis An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Liver Disease [ CLOSED ] Study of seladelpar in subjects with primary biliary cholangitis (PBC)
Liver Disease Registry Study of Adult Patients with Primary Sclerosing Cholangitis (PSC)
Transplant [ CLOSED ] Prevention of Hepatitis C with Antiviral HCV Therapy After Liver and/or Kidney Transplant
Cirrhosis of the Liver Red-C 3131: Study of Rifaximin in Preventing Hepatic Encephalopathy (HE) in Patients with Advanced Liver Cirrhosis
Liver Disease Advancing Liver Therapeutic Approaches (ALTA) in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS)
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE